Q&A with Oscar CEO Mario Schlosser on how health care data can transform the industry as Alphabet invests $375M in the provider, following Capital G and Verily
IN THE LATE 1990s, two graduate students named in Stanford's computer science department set out to organize the world's information.
Context & Ripple Effects
Alphabet's $375M check is its third distinct bet on Oscar, and each came through a different vehicle: Google Capital took a $32.5M stake at a $1.75B valuation back in 2015, and Capital G plus Verily joined Founders Fund's $165M round earlier in 2018 at a reported $3.2B. The new money folds those separate positions into a single, larger commitment.
The timing matters because Verily had already been [[a:927040|talking with insurers about joint bids on contracts covering hundreds of thousands of patients]]. Owning a bigger piece of an actual insurer turns those partnership conversations into something closer to an in-house capability — Schlosser's Q&A frames the thesis as health care data transforming the industry, not just cheaper premiums.
First-order effects
- Oscar gains a $375M war chest and Alphabet as anchor investor, extending a funding arc that began with the $145M raise at a $1.5B valuation in 2015.
- Alphabet now holds exposure to a licensed insurer directly, alongside Capital G and Verily — meaning its health-care strategy no longer depends solely on Verily's joint-bid partnerships.
Second-order effects
- Incumbent insurers competing against Oscar now face a rival whose underwriting ambitions are backed by Alphabet's data infrastructure, pressuring them to accelerate their own analytics investments or partnership deals.
- Other diversified tech investors watching Alphabet's layered approach — venture arm, growth fund, and operating subsidiary all in one startup — have a template for entering regulated industries without acquiring them outright.
Third-order effects
- If the pattern holds, health insurance competition shifts toward whoever controls claims data and the algorithms that read it, with Alphabet positioned to influence the sector through minority stakes rather than headline-grabbing acquisitions.
- The multi-vehicle investment structure points to big tech treating regulated, data-rich industries as portfolios of staged bets — a structural alternative to the merger route that regulators scrutinize.
The trend: Big tech is building positions in regulated, data-intensive industries like health insurance through stacked investment vehicles rather than outright ownership, with Alphabet's escalating Oscar stakes as the clearest example.